Rhythm Biosciences Limited

RHY

AU000000RHY2

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 01:42:11 2024-07-05 am EDT			5-day change	1st Jan Change
0.062 ^AUD	+1.64%		0.00%	-54.07%

May. 22	Rhythm Biosciences' Buttula to Revert to Nonexecutive Chair Role; Shares Up 3%	MT
Apr. 24	Rhythm Biosciences Appoints CEO; Shares Down 3%	MT

Rhythm Biosciences Limited Appoints Otto Buttula as Chairman with Effect from 28 October 2019

October 28, 2019 at 12:51 am EDT

Rhythm Biosciences Limited announced the appointment of Mr. Otto Buttula as the Company's Chairman with effect from 28 October 2019.

Latest news about Rhythm Biosciences Limited

Rhythm Biosciences' Buttula to Revert to Nonexecutive Chair Role; Shares Up 3%	May. 22	MT
Rhythm Biosciences Appoints CEO; Shares Down 3%	Apr. 23	MT
Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3%	Mar. 20	MT
Rhythm Biosciences Limited(ASX:RHY) dropped from S&P/ASX All Ordinaries Index	Mar. 17	CI
Rhythm Biosciences Limited(ASX:RHY) dropped from S&P/ASX Emerging Companies Index	Mar. 17	CI
Rhythm Biosciences Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28	CI
Rhythm Biosciences Seeks to Raise AU$6.6 Million Via Rights Offer; Shares Fall 29%	Feb. 09	MT
Rhythm Biosciences Limited Announces Resignation of Rachel David as Non-Executive Director	Dec. 28	CI
Rhythm Biosciences Ltd Announces the Appointment of James Barrie as Joint Company Secretary, Effective 1 January 2024	Dec. 13	CI
Rhythm Biosciences Identifies Lung Cancer Biomarkers from Blood Samples; Shares Fall 6%	Nov. 23	MT
Rhythm Biosciences Limited Announces Resignation of Paul Smith as CFO	Nov. 15	CI
Rhythm Biosciences Limited Announces Executive Changes	Nov. 15	CI
Rhythm Biosciences Receives First Tranche of R&D Tax Rebate	Nov. 14	MT
Rhythm Biosciences' Breast Cancer Diagnostic Test Shows Positive Results	23-09-22	MT
Rhythm Biosciences Joins Forces to Automate Cancer Test Kit	23-09-13	MT
Rhythm Biosciences Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
Rhythm Biosciences Appoints Director to Newly Created Deputy Chair Role	23-07-04	MT
Rhythm Biosciences Signs Deal for UK Entry of Cancer Test	23-05-24	MT
Rhythm Biosciences Secures UK Certification for Diagnostic Test; Shares Surge 89%	23-05-17	MT
Rhythm Biosciences CEO Steps Down; Shares Slump 13%	23-04-19	MT
Rhythm Biosciences Limited Announces Management Changes	23-04-18	CI
Rhythm Biosciences Ltd Announces Executive Changes	23-04-18	CI
Rhythm Biosciences Pulls Out TGA Submission for Colorectal Cancer Diagnostic Kit	23-03-06	MT
Rhythm Biosciences Limited Provides Update to TGA Submission for ColoSTAT® Test-Kit	23-03-05	CI
Rhythm Biosciences Shares Suspended from Australian Bourse	23-03-03	MT

Chart Rhythm Biosciences Limited

Duration

Period

More charts

Rhythm Biosciences Ltd is an Australia-based medical diagnostics company. The Company is engaged in delivering simple, affordable blood tests for accurate and early detection of cancers. It is focused on improving patient outcomes through detection at the earliest possible stage, reducing the global burden of cancer and saving lives. The Company has developed ColoSTAT, a blood test for the detection of Colorectal Cancer (CRC). If diagnosed early, colorectal cancer is curable. The ColoSTAT Test-Kit measures five specific protein biomarkers that indicate the likelihood of CRC. The test is an alternative for individuals who are unable or unwilling to participate in current screening programs. It is being updated to meet the IVDR (In vitro diagnostic medical devices regulation) regulatory standards. It is focused on working with likeminded global partners to achieve commercialization and distribution of these simple solutions.

Sector

Biotechnology & Medical Research

Calendar

2024-08-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
RHYTHM BIOSCIENCES LIMITED	-54.07%	10.56M
GUARDANT HEALTH, INC.	+6.28%	3.52B
IOVANCE BIOTHERAPEUTICS, INC.	-10.46%	2.04B
BGI GENOMICS CO., LTD.	-27.73%	1.82B
VERACYTE, INC.	-21.74%	1.65B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+6.72%	928M
CAREDX, INC	+29.42%	811M
SEEGENE, INC.	-8.30%	702M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-27.76%	522M
CURIOX BIOSYSTEMS CO., LTD	-12.92%	255M

Bio Diagnostics & Testing